-
Lotiglipron is a non-peptide glucagon-like peptide-1
receptor agonist developed as a
weight loss drug by Pfizer. It was
withdrawn from
development after...
-
current peptide GLP-1
agonists and is
expected to be cheaper.
Danuglipron Lotiglipron Pratt E, Ma X, Liu R,
Robins D,
Coskun T,
Sloop KW, et al. (June 2023)...
-
commonly reported adverse events were nausea, diarrhea, and vomiting.
Lotiglipron Orforglipron Griffith DA,
Edmonds DJ,
Fortin JP,
Kalgutkar AS, Kuzmiski...
- VK2735 BLX7006
Supaglutide ASC30
Danuglipron Aleniglipron(GSBR-1290)
Lotiglipron Orforglipron CT-996 CT-388 Antagonists: [9-39]-GLP-1 T-0632 GLP1R0017...
